EDITORIAL COMMENT

Urology. 2019 Jul:129:151. doi: 10.1016/j.urology.2019.01.059.

Authors

Mohit Gupta¹, Phillip M Pierorazio¹

Affiliation

¹ The James Buchanan Brady Urological Institute, Department of Urology, Baltimore, MD; The Johns Hopkins University School of Medicine, Baltimore, MD.

PMID: 31234995
DOI: 10.1016/j.urology.2019.01.059

No abstract available

Publication types

Comment

MeSH terms

Carcinoma, Transitional Cell*
Humans
Neoadjuvant Therapy
Urologic Neoplasms*